Retatrutide, from Soma Pharmaceuticals , is receiving significant attention as a innovative method for weight regulation. This dual-action medication integrates the properties of a GLP-1 receptor agonist and a GIP receptor activator , designed to not only promote weight loss but also address related metabolic conditions . Preliminary patient studie